iifl-logo-icon 1

Hester Biosciences Ltd Share Price

2,709.1
(-1.34%)
Jul 19, 2024|09:44:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,745.8
  • Day's High2,745.8
  • 52 Wk High2,880.45
  • Prev. Close2,745.8
  • Day's Low2,589.15
  • 52 Wk Low1,292.85
  • Turnover (lac)77.91
  • P/E85.89
  • Face Value10
  • Book Value375.63
  • EPS31.93
  • Mkt. Cap (Cr.)2,304.59
  • Div. Yield0.22
No Records Found

Hester Biosciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

2,745.8

Prev. Close

2,745.8

Turnover(Lac.)

77.91

Day's High

2,745.8

Day's Low

2,589.15

52 Week's High

2,880.45

52 Week's Low

1,292.85

Book Value

375.63

Face Value

10

Mkt Cap (₹ Cr.)

2,304.59

P/E

85.89

EPS

31.93

Divi. Yield

0.22

Hester Biosciences Ltd Corporate Action

2 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

23 Aug 2023

12:00 AM

BookCloser

arrow

17 May 2023

12:00 AM

Dividend

Dividend Amount: 8

arrow

23 Aug 2023

12:00 AM

AGM

Announcement Date: 23 Aug, 2023

arrow

Hester Biosciences Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Hester Biosciences Ltd SHAREHOLDING SNAPSHOT

19 Jul, 2024|03:52 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 9.45%

Foreign: 9.45%

Indian: 44.28%

Non-Promoter- 0.52%

Institutions: 0.52%

Non-Institutions: 45.74%

Custodian: 0.00%

Share Price

Hester Biosciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

8.51

8.51

8.51

8.51

Preference Capital

0

0

0

0

Reserves

283.88

259.93

229.07

194.57

Net Worth

292.39

268.44

237.58

203.08

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

219.35

208.47

169.42

134.78

yoy growth (%)

5.21

23.04

25.7

9.32

Raw materials

-61.7

-53.39

-22.74

-23.31

As % of sales

28.12

25.61

13.42

17.29

Employee costs

-39.11

-33.45

-37.15

-22.28

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

53.25

60.06

41.22

43.7

Depreciation

-9.5

-9.63

-9.38

-5.45

Tax paid

-13.73

-14.88

-10

-13.14

Working capital

22.11

12.78

30.69

13.13

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

5.21

23.04

25.7

9.32

Op profit growth

-15.86

36.55

6.29

20.73

EBIT growth

-12.94

38.35

0.52

26.8

Net profit growth

-0.96

27.79

2.17

22.52

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

304.55

266.09

235.01

214.33

183.27

Excise Duty

0

0

0

0

0

Net Sales

304.55

266.09

235.01

214.33

183.27

Other Operating Income

0

0

0

0

0

Other Income

15.25

19.56

14.16

4.68

6.37

Hester Biosciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,594.25

125.293,82,370.02867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,584.8

77.221,21,645.675310.652,259507.93

Cipla Ltd

CIPLA

1,506.65

32.741,21,616.251,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,185.65

34.71,19,268.911,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,667.5

25.951,11,193.661,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Hester Biosciences Ltd

Management

Register Office

Registrar Office

Chairman & Non Executive Dir.

Bhupendra V Gandhi

Non-Exec & Non-Independent Dir

Sanjiv D Gandhi

Non Executive Director

Nina Gandhi

Independent Non Exe. Director

Sandhya Patel

Independent Non Exe. Director

Ashok Bhadakal

Independent Non Exe. Director

Ameet Desai

ED / MD / CEO / Promoter

Rajiv D Gandhi

Non-Exec & Non-Independent Dir

Ravin Gandhi

Executive Director

PRIYA RAJIV GANDHI

Independent Non Exe. Director

Anil Jain

Independent Non Exe. Director

Jatin Yagneshbhai Trivedi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. Since its incorporation in Apr 87, the Company has been engaged in the production and distribution of vaccines and health products. Headquartered in Ahmedabad, Gujarat, the Company is currently the second-largest maker of poultry vaccines in India, having acquired strong brand equity over the years. The Company principally engages in two business verticals, namely Poultry Healthcare and Animal Healthcare. Its products are registered with several countries, and internal agencies, and have gained widespread recognition in both India and international markets. It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services offered include over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The companys own production of veterinary vaccines
Read More

Company FAQs

What is the Hester Biosciences Ltd share price today?

Down Arrow

The Hester Biosciences Ltd shares price on N/A is Rs.₹2689 today.

What is the Market Cap of Hester Biosciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hester Biosciences Ltd is ₹2287.50 Cr. as of 19 Jul ‘24

What is the PE and PB ratio of Hester Biosciences Ltd?

Down Arrow

The PE and PB ratios of Hester Biosciences Ltd is 85.89 and 7.46 as of 19 Jul ‘24

What is the 52 Week High and Low of Hester Biosciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Hester Biosciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Hester Biosciences Ltd is ₹1292.9 and ₹2975.6 as of 19 Jul ‘24

What is the CAGR of Hester Biosciences Ltd?

Down Arrow

Hester Biosciences Ltd's CAGR for 5 Years at 9.91%, 3 Years at 3.98%, 1 Year at 61.21%, 6 Month at 78.45%, 3 Month at 68.81% and 1 Month at 31.73%.

What is the shareholding pattern of Hester Biosciences Ltd?

Down Arrow

The shareholding pattern of Hester Biosciences Ltd is as follows:
Promoters - 53.73 %
Institutions - 0.52 %
Public - 45.74 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.